Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.470
+0.470 (15.67%)
At close: Nov 22, 2024, 4:00 PM
3.509
+0.039 (1.14%)
After-hours: Nov 22, 2024, 7:56 PM EST

Perspective Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Jun '22 Jun '21 Jun '20 2019 - 2015
Market Capitalization
235113354411338
Upgrade
Market Cap Growth
1072.20%221.19%-19.99%-61.12%200.36%36.12%
Upgrade
Enterprise Value
-2998-19-144936
Upgrade
Last Close Price
3.474.022.473.097.985.55
Upgrade
PS Ratio
119.7778.656.48-11.233.88
Upgrade
PB Ratio
0.711.500.640.721.676.57
Upgrade
P/TBV Ratio
3.54147.820.640.721.686.73
Upgrade
EV/Sales Ratio
392.5368.42--4.863.74
Upgrade
Debt / Equity Ratio
0.010.03-0.010.010.18
Upgrade
Asset Turnover
0.010.02--0.251.07
Upgrade
Inventory Turnover
----6.077.75
Upgrade
Quick Ratio
9.530.6614.4725.3836.582.84
Upgrade
Current Ratio
9.601.0717.0726.1837.373.50
Upgrade
Return on Equity (ROE)
-27.02%-57.70%--9.79%-9.26%-51.42%
Upgrade
Return on Assets (ROA)
-14.35%-32.81%--5.95%-5.43%-23.98%
Upgrade
Return on Capital (ROIC)
-16.56%-38.66%--6.17%-5.74%-30.16%
Upgrade
Earnings Yield
-27.20%-41.23%-30.64%-16.57%-3.00%-9.17%
Upgrade
FCF Yield
-17.30%-33.68%-30.42%-18.17%-2.85%-10.42%
Upgrade
Buyback Yield / Dilution
-130.70%-88.39%-0.06%-36.74%-53.61%-0.83%
Upgrade
Total Shareholder Return
-130.70%-88.39%-0.06%-36.74%-53.61%-0.83%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.